One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study.

Kan-O K, Watanabe H, Chibana K, Suzukawa M, Tanaka A, Masaki K, Ohta S, Kabata H, Asano K, Ito R, Inoue H, Nakano T, Kanda H, Yamashita T, Obase Y, Kobayashi K, Sugimoto N, Ito Y, Ogata H, Takagi K, Ohshima N, Kinoshita T, Tashiro H, Takahashi K, Oishi K, Hirano T, Sakakibara H, Sennari K, Sugimoto Y, Shiroyama T, Fukahori S, Oguma T, Tomomatsu K, Shimada S, Kondo M, Akaba T, Yoshimi M, Moriuchi Y, Ujike M, Mitsui M, Shimizu K, Shindo Y, Takasawa S, Wakahara K, Uno T, Miyata J, Ishida A, Tsuji M, Shimada A, Okamoto I

Open source

DOI
10.1016/j.jaci.2026.05.006
Published
2026 Sep
Container
The Journal of allergy and clinical immunology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaci.2026.05.006,
  title = {One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study.},
  author = {Kan-O K and Watanabe H and Chibana K and Suzukawa M and Tanaka A and Masaki K and Ohta S and Kabata H and Asano K and Ito R and Inoue H and Nakano T and Kanda H and Yamashita T and Obase Y and Kobayashi K and Sugimoto N and Ito Y and Ogata H and Takagi K and Ohshima N and Kinoshita T and Tashiro H and Takahashi K and Oishi K and Hirano T and Sakakibara H and Sennari K and Sugimoto Y and Shiroyama T and Fukahori S and Oguma T and Tomomatsu K and Shimada S and Kondo M and Akaba T and Yoshimi M and Moriuchi Y and Ujike M and Mitsui M and Shimizu K and Shindo Y and Takasawa S and Wakahara K and Uno T and Miyata J and Ishida A and Tsuji M and Shimada A and Okamoto I},
  year = {2026},
  journal = {The Journal of allergy and clinical immunology},
  doi = {10.1016/j.jaci.2026.05.006},
  url = {https://doi.org/10.1016/j.jaci.2026.05.006}
}

RIS

TY  - JOUR
TI  - One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study.
AU  - Kan-O K
AU  - Watanabe H
AU  - Chibana K
AU  - Suzukawa M
AU  - Tanaka A
AU  - Masaki K
AU  - Ohta S
AU  - Kabata H
AU  - Asano K
AU  - Ito R
AU  - Inoue H
AU  - Nakano T
AU  - Kanda H
AU  - Yamashita T
AU  - Obase Y
AU  - Kobayashi K
AU  - Sugimoto N
AU  - Ito Y
AU  - Ogata H
AU  - Takagi K
AU  - Ohshima N
AU  - Kinoshita T
AU  - Tashiro H
AU  - Takahashi K
AU  - Oishi K
AU  - Hirano T
AU  - Sakakibara H
AU  - Sennari K
AU  - Sugimoto Y
AU  - Shiroyama T
AU  - Fukahori S
AU  - Oguma T
AU  - Tomomatsu K
AU  - Shimada S
AU  - Kondo M
AU  - Akaba T
AU  - Yoshimi M
AU  - Moriuchi Y
AU  - Ujike M
AU  - Mitsui M
AU  - Shimizu K
AU  - Shindo Y
AU  - Takasawa S
AU  - Wakahara K
AU  - Uno T
AU  - Miyata J
AU  - Ishida A
AU  - Tsuji M
AU  - Shimada A
AU  - Okamoto I
PY  - 2026
JO  - The Journal of allergy and clinical immunology
DO  - 10.1016/j.jaci.2026.05.006
UR  - https://doi.org/10.1016/j.jaci.2026.05.006
ER  -

APA

K, K., H, W., K, C., M, S., A, T., K, M., S, O., H, K., K, A., R, I., H, I., T, N., H, K., T, Y., Y, O., K, K., N, S., Y, I., H, O., K, T., N, O., T, K., H, T., K, T., K, O., T, H., H, S., K, S., Y, S., T, S., S, F., T, O., K, T., S, S., M, K., T, A., M, Y., Y, M., M, U., M, M., K, S., Y, S., S, T., K, W., T, U., J, M., A, I., M, T., A, S., & I, O. (2026). One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study.. The Journal of allergy and clinical immunology. https://doi.org/10.1016/j.jaci.2026.05.006

Source records